Correlation Between Crinetics Pharmaceuticals and Neurobo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Crinetics Pharmaceuticals and Neurobo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crinetics Pharmaceuticals and Neurobo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crinetics Pharmaceuticals and Neurobo Pharmaceuticals, you can compare the effects of market volatilities on Crinetics Pharmaceuticals and Neurobo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crinetics Pharmaceuticals with a short position of Neurobo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crinetics Pharmaceuticals and Neurobo Pharmaceuticals.
Diversification Opportunities for Crinetics Pharmaceuticals and Neurobo Pharmaceuticals
-0.52 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Crinetics and Neurobo is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Crinetics Pharmaceuticals and Neurobo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurobo Pharmaceuticals and Crinetics Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crinetics Pharmaceuticals are associated (or correlated) with Neurobo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurobo Pharmaceuticals has no effect on the direction of Crinetics Pharmaceuticals i.e., Crinetics Pharmaceuticals and Neurobo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Crinetics Pharmaceuticals and Neurobo Pharmaceuticals
Given the investment horizon of 90 days Crinetics Pharmaceuticals is expected to generate 0.53 times more return on investment than Neurobo Pharmaceuticals. However, Crinetics Pharmaceuticals is 1.88 times less risky than Neurobo Pharmaceuticals. It trades about -0.03 of its potential returns per unit of risk. Neurobo Pharmaceuticals is currently generating about -0.15 per unit of risk. If you would invest 5,840 in Crinetics Pharmaceuticals on August 24, 2024 and sell it today you would lose (137.00) from holding Crinetics Pharmaceuticals or give up 2.35% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 95.65% |
| Values | Daily Returns |
Crinetics Pharmaceuticals vs. Neurobo Pharmaceuticals
Performance |
| Timeline |
| Crinetics Pharmaceuticals |
| Neurobo Pharmaceuticals |
Crinetics Pharmaceuticals and Neurobo Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Crinetics Pharmaceuticals and Neurobo Pharmaceuticals
The main advantage of trading using opposite Crinetics Pharmaceuticals and Neurobo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crinetics Pharmaceuticals position performs unexpectedly, Neurobo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurobo Pharmaceuticals will offset losses from the drop in Neurobo Pharmaceuticals' long position.| Crinetics Pharmaceuticals vs. Viridian Therapeutics | Crinetics Pharmaceuticals vs. Cytokinetics | Crinetics Pharmaceuticals vs. Structure Therapeutics American | Crinetics Pharmaceuticals vs. Passage Bio |
| Neurobo Pharmaceuticals vs. Allarity Therapeutics | Neurobo Pharmaceuticals vs. Virax Biolabs Group | Neurobo Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Neurobo Pharmaceuticals vs. Biodexa Pharmaceticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |